© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Substance: Azelastine Hydrochloride
Chemical Formula: C22H24ClN3O·HCl
Common Uses: Prescription antihistamine nasal spray or ophthalmic solution for allergy symptoms
Appearance: White to almost white crystalline powder
Odor: Odorless
Molecular Weight: 418.37 g/mol
Solubility: Freely soluble in water and methanol
Primary Route of Exposure: Inhalation, skin contact, ingestion, eye contact during manufacture, formulation, or accidental spill in clinical or laboratory settings
Main Risks: Irritation of skin, eyes, and respiratory tract; possible allergic reactions
Acute Effects: Headache, drowsiness, taste disturbances, mild local irritation
Chronic Effects: No well-established carcinogenic, mutagenic, or reproductive risks in typical workplace exposure
Acute Ingestion: Nausea, vomiting, confusion in rare or excessive exposures
Inhalation: Possible nose, throat, or lung irritation if dusty or in powdered form
Eye Contact: Redness, pain, watering
Symbols/Labels: GHS pictograms relating to irritation and possible sensitization depending on country and jurisdictional requirements
Main Ingredient: Azelastine Hydrochloride (>98%)
Other Ingredients: Trace residual solvents or hydrates may be present from manufacturing
Impurities: Typically controlled under pharmacopoeial standards; unknowns negligible under GMP production
Physical State: Solid (bulk powder) or formulated solution (nasal/oral forms)
Additives in Formulations: Sodium chloride, benzalkonium chloride, water, and possibly other excipients in end-user products
Inhalation: Remove to fresh air; seek medical advice if symptoms persist
Skin Contact: Rinse thoroughly with soap and water; remove contaminated clothing
Eye Contact: Flush with plenty of water for at least fifteen minutes; get medical attention for persistent discomfort
Ingestion: Rinse mouth; drink water; consult a physician if accidental ingestion of powdered or raw material produces symptoms
Precautions: Workers benefit from prompt attention to exposures, especially in labs or production lines dealing with pure compound
Suitable Extinguishing Media: Water spray, dry chemical, carbon dioxide, foam
Hazards in Fire: Decomposition may produce hazardous fumes—hydrogen chloride, nitrogen oxides, carbon monoxide
Protective Equipment: Self-contained breathing apparatus, full protective clothing
Firefighting Challenges: Fine powders can present dust explosion hazards in poorly ventilated environments; avoid dust buildup
Evacuation: Nearby personnel should evacuate if significant material is burning or overheating due to risk of toxic smoke
Personal Precautions: Wear gloves, goggles, disposable gown or protective clothing; avoid raising dust
Environmental Precautions: Prevent entry into waterways or drains, particularly in large quantities (bulk spills)
Clean Up Methods: Scoop or vacuum powder into sealable containers; wipe residue with damp cloth; dispose of cleanup materials in accordance with local regulations
Decontamination: Rinse spill site with mild detergent and water after cleanup
Industry Learnings: Accidents pile up when safety equipment or ventilation gets bypassed; simple attention to rules keeps workplaces and people safe
Handling Practices: Manipulate in well-ventilated areas or fume hoods; avoid contact with eyes, skin, or clothing; minimize dust formation
Bathroom or Home Use: Nasal sprays and drops safe for end-users when following instructions; bulk compound always handled in controlled environments
Storage Recommendations: Store in tightly closed containers; keep away from direct light, high heat, and moisture; respect recommended temperature conditions
Compatibility: Keep separate from strong oxidizers and acids to avoid reactions
Spill Management: Staff must know how to respond to accidental releases; annual drills and safety reminders offer practical preparation
Exposure Limits: Occupational limits for Azelastine Hydrochloride not universally established; minimize exposure as for all pharmaceutical actives
Engineering Controls: Local exhaust ventilation, fume hood, or dust extraction systems minimize airborne exposure
Protective Gear: Safety goggles, gloves, lab coats or disposable coveralls, dust masks or respirators for high-dust environments
Hygiene Measures: Wash hands and exposed skin before eating, drinking, or leaving the work area; laundering work clothing prevents family exposure
Monitoring: Routine air and surface sampling in pharmaceutical manufacturing and research sites reveal exposure hotspots; data guides upgrades
Form: White to off-white crystalline powder in raw state; clear solution when diluted in nasal spray forms
Odor: No discernible odor
Melting Point: Around 225°C with decomposition
Solubility: Easily dissolves in water, methanol, and ethanol
pH (Solution): Near 6.5 for formulated nasal/eye products
Stability Under Storage: Remains stable under normal temperatures and pressures if dry and packaged properly
Chemical Stability: Material remains stable when kept dry and sealed away from light and air
Hazardous Reactions: Violent reactions rare; could break down if mixed with strong oxidizers or heated excessively
Decomposition Products: Hydrogen chloride, oxides of nitrogen, carbon monoxide in uncompromising fire or decomposition settings
Incompatible Materials: Strong acids, strong oxidizers accelerate breakdown
Workplace Takeaway: Small mistakes—a leaky container or careless chemical mix—can snowball; storing away from incompatible chemicals remains basic but essential
Routes of Exposure: Inhalation, ingestion, dermal contact, accidental eye splash
Acute Toxicity: Low toxicity—dizziness, nausea, mild sedation some experience in large accidental exposures, not typical in daily pharmaceutical work
Skin/Eye Irritation: Can cause redness, burning sensation, or itching
Sensitization: Rare, though repeat skin contact in susceptible people might cause rashes; laboratory handling policies help reduce incidents
Long-term Concerns: Animal studies suggest very high, repeated doses can cause liver changes, but ordinary workplace and patient exposures do not approach these levels
Aquatic Toxicity: Limited research points to moderate effects in water environments at high concentrations
Persistence: Incomplete environmental breakdown has potential to affect aquatic organisms downstream of improper pharmaceutical wastewater disposal
Bioaccumulation: Low likelihood in wildlife based on current evidence
Environmental Stewardship: Proper drug disposal, wastewater management in manufacturing, consumer education on medicine return programs all play a role in protecting watersheds and wildlife
Community Action: Advocates and local authorities can encourage regular pharmaceutical take-back initiatives, keeping unused medicines out of water and landfill
Safe Disposal: Incinerate in approved facility if handling bulk compound; return unused drug forms through take-back programs
Regulatory Requirements: Follow national or local regulations for hazardous pharmaceutical waste, including recordkeeping and manifest when needed
Consumer Guidance: Never flush azelastine products down the drain; most pharmacies participate in medication disposal programs
Operational Practices: Regular review of disposal procedures in labs and clinics reduces incidents of unsafe tossing of expired or spilled material
Transport Classification: Azelastine Hydrochloride typically does not fall under dangerous goods rules for ground or air freight
Packing Requirements: Well-sealed containers, sometimes with ice-packs for longer routes or shipment of finished dosage forms; avoid direct contact and spillage
Labelling: Proper ingredient and hazard labeling reduces mix-ups and accidental misuse, especially in global shipping
Transit Risks: In bulk, accidental rupture risks inhalation or local contamination; staff must receive training to deal with minor leaks or spills en route
Pharmaceutical Approval: Authorized by national drug agencies for prescription antihistamine use; subject to periodic safety review
Workplace Safety Requirements: Governing bodies expect adherence to industrial hygiene standards in labs and factories
Labeling Laws: Active pharmaceutical ingredients require hazard, precaution, and content labeling per global harmonized systems
Oversight Mechanisms: Agencies carry out inspections and enforce reporting of any adverse events or workplace incidents involving pharmaceutical actives
